Note: Ingredients listed on restricted chemical lists
EC/CAS
108-88-3
Name of the chemical
Toluene
Concentration
≥10-≤25
EC/CAS
67-56-1
Name of the chemical
Methanol
Concentration
≥10-≤20
EC/CAS
108-10-1
Name of the chemical
4-methylpentan-2-one; isobutyl methyl ketone (MIBK)
Concentration
≤1.7
EC/CAS
98-56-6
Name of the chemical
4-Chloro-alpha,alpha,alpha-trifluorotoluene
Concentration
<1
General Information
Version
20.01
Revision date
2025-07-31
Product name
Wash Thinner
Manufacturer Name
M. L. CAMPBELL
Emergency telephone
(800) 424-9300
Icons in SDS
Company Information
company name
M. L. CAMPBELL
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H225, H304, H315, H319, H335, H336, H351, H360, H370, H373
Hazard statements
Code
Statements
H225
Highly Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
Ingredient(s) with unknown acute toxicity
8.2% (oral), 25.7% (dermal), 8.2% (inhalation)
Signal word
Danger
Hazard statements
Highly flammable liquid and vapor. Harmful if swallowed, in contact with skin or if inhaled. May be fatal if swallowed and enters airways. Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation. May cause drowsiness or dizziness. Suspected of causing cancer. May damage fertility or the unborn child. Causes damage to organs. May cause damage to organs through prolonged or repeated exposure.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Wear protective gloves, protective clothing, eye protection, face protection, or hearing protection. Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. Use only outdoors or in a well- ventilated area. Do not breathe vapor. Do not eat, drink or smoke when using this product. Wash thoroughly after handling.
Response
IF exposed or concerned Call a POISON CENTER or doctor. IF INHALED Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER or doctor if you feel unwell. IF SWALLOWED: Immediately call a POISON CENTER or doctor. Rinse mouth. Do NOT induce vomiting. IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water. IF ON SKIN: Call a POISON CENTER or doctor if you feel unwell. If skin irritation occurs: Get medical advice or attention. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice or attention.
Storage
Store locked up. Store in a well-ventilated place. Keep container tightly closed.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations.
Supplemental label elements
DELAYED EFFECTS FROM LONG TERM OVEREXPOSURE. Contains solvents which can cause permanent brain and nervous system damage. Intentional misuse by deliberately concentrating and inhaling the contents can be harmful or fatal. WARNING: This product contains chemicals known to the State of California to cause cancer and birth defects or other reproductive harm. FOR PROFESSIONAL USE ONLY. Please refer to the SDS for additional information. Keep out of reach of children. Do not transfer contents to other containers for storage.
2.3 Other hazards
None known.
2.1 Classification of the substance or mixture
ACUTE TOXICITY (oral) - Category 4 ACUTE TOXICITY (dermal) - Category 4 ACUTE TOXICITY (inhalation) - Category 4 SKIN CORROSION/IRRITATION - Category 2 SERIOUS EYE DAMAGE/ EYE IRRITATION - Category 2A CARCINOGENICITY - Category 2 TOXIC TO REPRODUCTION - Category 1B SPECIFIC TARGET ORGAN TOXICITY (SINGLE EXPOSURE) - Category 1 SPECIFIC TARGET ORGAN TOXICITY (SINGLE EXPOSURE) (Respiratory tract irritation) - Category 3 SPECIFIC TARGET ORGAN TOXICITY (SINGLE EXPOSURE) (Narcotic effects) - Category 3 SPECIFIC TARGET ORGAN TOXICITY (REPEATED EXPOSURE) - Category 2 ASPIRATION HAZARD - Category 1 Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 8.2% (oral), 25.7% (dermal), 8.2% (inhalation)